Senti BiosciencesSNTI
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 15 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings, up 3 from Q3 2024. 3 opened new positions and 1 sold out. The largest holders were NEA Management Company, LLC ($1.6M), Vanguard Group Inc. ($342K) and Renaissance Technologies ($181K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Cathie Wood (0.0% of ARK Investment Management's portfolio).
- Company
- Senti Biosciences Inc.
- CUSIP
- 81726A209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $263K |
| Exits | 1 | $3K |
All 13F filers, Q3 2024 → Q4 2024: 83,639 shares bought and 180,746 shares sold, net −97,107 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| NEA Management Company, LLC | 0.09% | No change | 442,615 | $1.6M |
| Vanguard Group Inc. | 0.00% | No change | 97,467 | $342K |
| Renaissance Technologies | 0.00% | New | 51,600 | $181K |
| Geode Capital Management, LLC | 0.00% | Add +0.7% | 27,494 | $97K |
| UBS Group AG | 0.00% | Add +80.7% | 18,969 | $67K |
| Virtu Financial LLC | 0.00% | New | 13,356 | $47K |
| State Street Corp. | 0.00% | New | 10,010 | $35K |
| BlackRock, Inc. | 0.00% | No change | 4,004 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -56.6% | 1,023 | $4K |
| SBI Securities Co., Ltd. | 0.00% | — | 337 | $1K |
| Morgan Stanley | 0.00% | Reduce -71.7% | 160 | $562 |
| Bank of America Corp. | 0.00% | Reduce -65.8% | 120 | $421 |
| Barclays PLC | 0.00% | Reduce -94.0% | 30 | $105 |
| ARK Investment Management | 0.00% | Reduce -100.0% | 28 | $97 |
| Citigroup Inc. | 0.00% | Reduce -99.4% | 1 | $4 |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.